PLANTATION, Fla., March 25, 2021 /CNW/ - Akumin Inc. (NASDAQ: AKU)
(TSX: AKU) ("Akumin" or the "Company") will host a
conference call at 8:30 a.m. Eastern
Time, April 1, 2021, to
discuss its fourth quarter and yearend 2020 financial results.
The Company adopted U.S. GAAP as the basis of preparation for
the 2020 Annual Financial Statements effective for the fiscal
year-ended December 31, 2020, after
its common shares commenced trading on the NASDAQ on September 2, 2020 and becoming an "SEC Issuer"
for purposes of the Canadian Securities Administrators' National
Instrument 51-102 -- Continuous Disclosure Obligations. The
Company expects to also release interim statements for the 3-, 6-,
and 9- month periods ended March 31,
2020, June 30, 2020, and
September 30, 2020, respectively, in
U.S. GAAP together with its release of its 2020 Annual Financial
Statements, all of which the Company expects to be available prior
to the conference call.
To access the conference call, dial toll-free in Canada or the U.S. 888-231-8191 or, for
international callers, 647-427-7450. Participants are asked
to connect at least 10 minutes prior to the beginning of the call
to ensure participation. There will also be simultaneous and
archived webcasts available at
https://akum.in/Q42020-ResultsCall. The webcast archive will
be available for 90 days. A replay of the conference call
will also be available until Tuesday, April
6, 2021 by calling 416-849-0833 or toll-free 1-855-859-2056,
using passcode number 3575808.
About Akumin
Akumin is a leading provider of freestanding, fixed-site
outpatient diagnostic imaging services in the United States with a network of owned
and/or operated imaging centers located in Florida, Texas, Pennsylvania, Delaware, Illinois, Kansas and Georgia. By combining our clinical expertise
with the latest advances in technology and information systems, our
centers provide physicians with imaging capabilities to facilitate
the diagnosis and treatment of diseases and disorders and may
reduce unnecessary invasive procedures, minimizing the cost and
amount of care for patients. Our imaging procedures include MRI,
CT, positron emission tomography (PET), ultrasound, diagnostic
radiology (X-ray), mammography, and other interventional
procedures.
Forward-Looking Information
Certain information in this press release constitutes
forward-looking information. In some cases, but not necessarily in
all cases, forward-looking information can be identified by the use
of forward-looking terminology such as "plans", "targets",
"expects" or "does not expect", "is expected", "an opportunity
exists", "is positioned", "estimates", "intends", "assumes",
"anticipates" or "does not anticipate" or "believes", or variations
of such words and phrases or state that certain actions, events or
results "may", "could", "would", "might", "will" or "will be
taken", "occur" or "be achieved". In addition, any statements that
refer to expectations, projections or other characterizations of
future events or circumstances contain forward-looking information.
Statements containing forward-looking information are not
historical facts but instead represent management's expectations,
estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of
opinions, assumptions and estimates that, while considered
reasonable by Akumin as of the date of this press release, are
subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, level of activity,
performance or achievements to be materially different from those
expressed or implied by such forward-looking information, including
but not limited to the factors described in greater detail in the
"Risk Factors" section of our Management Discussion and Analysis
dated November 11, 2020, which is
available at www.sedar.com and www.sec.gov. These factors are not
intended to represent a complete list of the factors that could
affect Akumin; however, these factors should be considered
carefully. There can be no assurance that such estimates and
assumptions will prove to be correct. The forward-looking
statements contained in this press release are made as of the date
of this press release, and Akumin expressly disclaims any
obligation to update or alter statements containing any
forward-looking information, or the factors or assumptions
underlying them, whether as a result of new information, future
events or otherwise, except as required by law.
SOURCE Akumin Inc.